We are live on ! Find out more
DCMM

DG Capital Management (Massachusetts) Portfolio holdings

AUM $102M
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
10 Year Est. Return
AUM
$175M
AUM Growth
+$6.37M
Cap. Flow
-$4.6M
Cap. Flow %
-2.62%
Top 10 Hldgs %
28.08%
Holding
74
New
14
Increased
15
Reduced
33
Closed
12

Top Buys

Rank Stock Value
1
FDX icon
FedEx
FDX
+$3.98M
2
ADBE icon
Adobe
ADBE
+$3.85M
3
TXN icon
Texas Instruments
TXN
+$3.49M
4
AET
Aetna Inc
AET
+$3.48M
5
MSFT icon
Microsoft
MSFT
+$3.11M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 20.23%
3 Financials 13.71%
4 Communication Services 11.89%
5 Industrials 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.9B
$8.66M 4.94%
27,480
-225
-0.8% -$67.7K
AAL icon
2
American Airlines Group
AAL
$9.58B
$6.54M 3.73%
152,232
+2,617
+2% +$102K
AMGN icon
3
Amgen
AMGN
$203B
$5.76M 3.28%
48,630
-20,580
-30% -$2.38M
MU icon
4
Micron Technology
MU
$1.04T
$4.32M 2.46%
131,140
+47,005
+56% +$1.28M
ADBE icon
5
Adobe
ADBE
$89.5B
$4.32M 2.46%
+59,645
New +$3.85M
FDX icon
6
FedEx
FDX
$74.5B
$4.31M 2.46%
+28,475
New +$3.98M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$3.9T
$3.86M 2.2%
133,485
-126,405
-49% -$3.43M
LLY icon
8
Eli Lilly
LLY
$1.07T
$3.86M 2.2%
62,030
-8,245
-12% -$492K
NVS icon
9
Novartis
NVS
$295B
$3.82M 2.18%
47,101
-12,599
-21% -$991K
GILD icon
10
Gilead Sciences
GILD
$161B
$3.8M 2.17%
45,815
-31,420
-41% -$2.45M
NXPI icon
11
NXP Semiconductors
NXPI
$68B
$3.8M 2.17%
57,390
-2,035
-3% -$125K
LVS icon
12
Las Vegas Sands
LVS
$30.5B
$3.77M 2.15%
49,519
+4,165
+9% +$317K
DAL icon
13
Delta Air Lines
DAL
$55.9B
$3.77M 2.15%
97,410
-14,910
-13% -$563K
SNY icon
14
Sanofi
SNY
$104B
$3.76M 2.15%
70,775
-14,555
-17% -$773K
AET
15
DELISTED
Aetna Inc
AET
$3.73M 2.13%
+46,020
New +$3.48M
MON
16
DELISTED
Monsanto Co
MON
$3.71M 2.12%
29,750
+3,620
+14% +$424K
TXN icon
17
Texas Instruments
TXN
$255B
$3.57M 2.04%
+74,755
New +$3.49M
MJN
18
DELISTED
Mead Johnson Nutrition Company
MJN
$3.46M 1.97%
37,110
+1,420
+4% +$124K
PARA
19
DELISTED
Paramount Global Class B
PARA
$3.37M 1.92%
54,230
-4,955
-8% -$295K
VIAB
20
DELISTED
Viacom Inc. Class B
VIAB
$3.28M 1.87%
37,860
+5,580
+17% +$474K
AGN
21
DELISTED
Allergan plc
AGN
$3.21M 1.83%
14,408
+1,373
+11% +$284K
MSFT icon
22
Microsoft
MSFT
$2.84T
$3.2M 1.83%
+76,755
New +$3.11M
MDLZ icon
23
Mondelez International
MDLZ
$77.7B
$3.05M 1.74%
81,205
-165
-0.2% -$6.03K
ABBV icon
24
AbbVie
ABBV
$458B
$2.95M 1.68%
52,250
+12,910
+33% +$677K
SLB icon
25
SLB Ltd
SLB
$77.8B
$2.92M 1.67%
24,790
-7,720
-24% -$796K

Similar funds

DG Capital Management (Massachusetts)'s Q2 2014 Portfolio in Review

As of Q2 2014, DG Capital Management (Massachusetts) held 74 positions worth $175M, up 3.8% from $169M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

DG Capital Management (Massachusetts)'s Q2 2014 filing shows 14 new, 15 increased, 33 reduced and 12 closed positions. Its largest new stake was FedEx: 28,475 shares worth $4.31M. The largest sale was Alphabet (Google) Class C, an estimated $3.43M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • DG Capital Management (Massachusetts)'s largest Q2 2014 buy was FedEx: 28,475 shares worth $4.31M.
  • DG Capital Management (Massachusetts) added most to Honeywell in Q2 2014, an estimated $1.42M increase.
  • DG Capital Management (Massachusetts)'s biggest Q2 2014 reduction was Alphabet (Google) Class C, cutting an estimated $3.43M.
  • DG Capital Management (Massachusetts) fully exited Dunkin' Brands Group, Inc. in Q2 2014, selling an estimated $2.79M.
  • DG Capital Management (Massachusetts)'s ten largest holdings make up 28% of its $175M portfolio in Q2 2014.
  • DG Capital Management (Massachusetts) opened 14 new positions and closed 12 in Q2 2014.
  • DG Capital Management (Massachusetts)'s portfolio value rose 3.8% quarter-over-quarter to $175M.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q2 2014, filed 8 Aug 2014.